What is myofunctional therapy, and what does the evidence actually show?

What is myofunctional therapy, exactly?

Myofunctional therapy is a programme of repeated mouth and throat exercises aimed at how those muscles rest and work, not at any one diagnosis. The 2015 meta-analysis in Sleep by Camacho and colleagues puts the mechanics plainly: "MT is composed of isotonic and isometric exercises that target oral (lip, tongue) and oropharyngeal structures (soft palate, lateral pharyngeal wall)." Cochrane's 2020 review of the same field describes the purpose rather than the anatomy, calling it "combinations of oropharyngeal exercises - i.e. mouth and throat exercises" that "typically include both isotonic and isometric exercises involving several muscles and areas of the mouth, pharynx and upper respiratory tract, to work on functions such as speaking, breathing, blowing, sucking, chewing and swallowing." Two descriptions, one practice. Neither of them mentions a device, a drug, or a procedure — it is drilling, repeated over weeks.

The drills themselves are unglamorous and specific. Camacho's paper lists them: "For soft palate exercises, patients pronounce oral vowel sounds either continuously (isometric exercises) or intermittently (isotonic exercises)." For the tongue, the same paper describes "moving the tongue along the superior and lateral surfaces of the teeth, positioning the tongue tip against the anterior aspect of the hard palate, pressing the entire tongue against the hard and soft palate, and forcing the tongue onto the floor of the mouth." If that sounds closer to physiotherapy than to anything you would recognise from a sleep clinic, that is the right instinct.

The condition the practice is built around has its own name. ASHA's Practice Portal defines orofacial myofunctional disorders as "movement patterns that involve oral and orofacial musculature, which result in incorrect positioning of the tongue at rest and during swallowing, breathing, and speech production", and states that the "primary purpose of orofacial myofunctional therapy (OMT) is to create an oral environment in which typical processes of orofacial and dental growth and development can take place and be maintained". SleepClinicFinder flags myofunctional therapy providers as a separate vertical for exactly that reason: the service sits between dentistry, speech pathology, and sleep medicine rather than inside any one of them.

Who provides myofunctional therapy — and how do I check their credentials?

ASHA describes myofunctional therapy as a service delivered by a specific profession working inside a wider team: "Orofacial myofunctional interventions are conducted by appropriately trained speech-language pathologists (SLPs) as part of a collaborative team. SLPs provide these services as members of interprofessional teams that include the individual, family or caregivers, and relevant professionals (e.g., medical, dental, orthodontic personnel)." The same page adds a training condition in its own words — SLPs serving this population "should be specifically educated and appropriately trained to do so". The referral network around that provider is long and published verbatim: allergist, orofacial myologist, dentist, lactation consultant, occupational therapist, oral surgeon, orthodontist, otolaryngologist, plastic surgeon, respiratory therapist, sleep apnea specialist. One person does not own this problem. Read that list as a map rather than a to-do list: it names the professions a myofunctional therapy provider is expected to be talking to, and it marks the questions that sit outside their own remit.

In Ontario there is a title rule worth knowing before you book. CASLPO, the provincial college, states that "anyone who uses the protected title 'audiologist' or 'speech-language pathologist' (including a variation or abbreviation) in Ontario must be registered with the College of Audiologists and Speech-Pathologists of Ontario", and that the same requirement applies to "anyone who holds themselves out as authorized to provide services" under those titles. The College publishes a public register so that registration can be checked directly rather than taken on trust.

What we will not tell you is what any other title means in law. Whether "myofunctional therapist" on its own is a regulated designation in Ontario is a question we could not answer from any source we fetched, so this guide asserts nothing about it in either direction. The workable substitute is a question you can ask in one line: which regulatory college are you registered with, and under what name should I look you up? SleepClinicFinder flags a practice as offering myofunctional therapy only where the practice's own published materials say so, and we store the supporting quote and source page behind every flag — but a service flag is not a credential check, and the college register is the only place that answer comes from.

• Ask which regulatory college the provider is registered with, and under which name.
• Ask what training in orofacial myofunctional work they hold, and from whom.
• Ask who else is involved — dentist, orthodontist, ENT, sleep physician — and who talks to whom.
• Ask what happens to the plan if a structural airway problem is found partway through.

What actually happens in a myofunctional therapy session?

Sessions revolve around a small number of targets that ASHA names directly: "Isotonic and isometric exercises target the lips and tongue to promote a closed-mouth resting posture and nasal breathing." Building toward that posture involves awareness work before strength work — ASHA describes "exercises to build (a) awareness of the tongue, lip, and jaw as well as (b) the habit of a closed-mouth resting posture", listing "oral tactile stimulation and tongue movements without assistance from the jaw, such as the tongue tip to the alveolar ridge or tongue clicks against the palate". The rationale ASHA gives for the posture goal is one sentence long: "Achieving lip closure at rest can serve to stabilize a nasal pattern of breathing." Sessions are teaching appointments. The repetitions happen at home. What is being taught, on this description, is a habit rather than a manoeuvre — which is why the practice schedule between visits carries more weight than any single appointment does.

How much home practice? The only figures we can source are the ones published trials used, and they should be read as study protocols rather than as a description of any clinic's programme. Camacho's review reports a wide spread across the studies it pooled: "MT was performed for as little as 5 min, twice daily, 4 days a week for 2 mo to as many as 10 min, three to five times daily for 3 mo." Cochrane's included trials ran a similar span — "the studies' duration ranged from two to four months". Those are research doses. Ask the provider what theirs is, in writing.

One sequencing rule shows up before any of this. ASHA states that OMT follows structural assessment rather than replacing it, describing the work that begins "after an allergist, orthodontist, and otolaryngologist (ENT) rules out or corrects structural or physiological impediments to nasal breathing", and adding that "closed-mouth posture cannot be consistently established until any airway interferences have been successfully resolved". As for where the service happens, ASHA is brief: orofacial myofunctional disorders "are usually treated in private practice, clinic, or hospital settings" and "are not typically treated in public school settings".

Do I need a diagnosis or referral before starting myofunctional therapy?

That decision is not a directory's to make, and it is not the therapy provider's either. ASHA draws the scope line twice on the same page: "diagnosing malocclusions or TMJD is not within the SLP's scope of practice", and, more broadly, "SLPs do not differentially diagnose medical conditions". Where sleep-disordered breathing is in the picture, the described role is contribution rather than diagnosis — SLPs "might be asked to provide input on the potential functional implications of obstructive sleep apnea and OMDs on the airway, respiration, and swallowing", and they "refer clients to physicians for further medical examination". So the diagnostic question routes to a physician — and the published diagnostic standard is a sleep study, not an examination of the mouth: CMAJ's clinical review of obstructive sleep apnea in adults states that "polysomnography is the gold standard for diagnosis". None of that is a comment on any individual provider's competence. It is a description of scope — a boundary a professional body drew around its own members' practice, published in plain sight.

That ordering matters practically as well as clinically, because the structural questions ASHA wants answered first — nasal obstruction, dental and orthodontic factors — are answered by different people than the ones who run the exercises. A myofunctional therapy plan built on top of an unexamined airway is a plan built on an assumption. The sequence ASHA describes puts allergist, orthodontist and ENT before the therapy, not alongside it.

If you are at the beginning of this and do not yet have a diagnosis, the practical first step is the referral conversation with a family physician, and the practical second is understanding what a sleep study in Ontario involves and who pays for it. SleepClinicFinder covers both — sleep study clinics across Peel, Halton and the GTA, and a separate guide on what the public plan covers — so that a conversation about myofunctional therapy starts after the diagnostic question has been settled rather than instead of it.

Does myofunctional therapy help with mouth breathing at night?

Nasal breathing and lip closure are stated targets of the exercises, which is not the same thing as a proven result. ASHA says the exercises "target the lips and tongue to promote a closed-mouth resting posture and nasal breathing", and that "achieving lip closure at rest can serve to stabilize a nasal pattern of breathing" — language about intent and mechanism, carefully hedged, from the professional body that defines the practice. The same page is firm that a blocked airway is not an exercise problem: "closed-mouth posture cannot be consistently established until any airway interferences have been successfully resolved." If nasal breathing is obstructed, the sequence ASHA describes sends the person to an ENT, allergist or orthodontist before the drills begin. Read that wording closely and it is doing two jobs at once: naming what the exercises aim at, and declining to promise the aim is reached.

Parents and partners usually arrive at this topic through a symptom rather than a term — an open mouth on the pillow, a dry mouth in the morning, a child who breathes audibly through the night. Those observations are worth raising with a physician or dentist, and they are not a diagnosis on their own. Nothing in the sources behind this guide supports treating a night-time breathing pattern as something to fix with exercises before someone has looked at why it is happening.

What the research measured is narrower than what people hope it measured. The trials pooled by Camacho and by Cochrane recorded apnea-hypopnea index, sleepiness scores, and snoring — not mouth breathing as an outcome in its own right. So there is no honest number to give you here, and we are not going to invent one. The reliable version of this conversation happens with the clinician who can examine the nose, the palate and the bite.

Does myofunctional therapy help snoring?

Two reviews looked at snoring and reached noticeably different levels of confidence. Camacho's 2015 meta-analysis reported that "polysomnography snoring decreased from 14.05 ± 4.89% to 3.87 ± 4.12% of total sleep time, P < 0.001, and snoring decreased in all three studies reporting subjective outcomes" — a large-looking change, drawn from a small pooled sample. Cochrane's 2020 randomised-trial review, comparing myofunctional therapy against sham therapy, was far more guarded: the therapy "may have little to no effect in reduction of snoring frequency but the evidence is very uncertain", a finding drawn from two studies with 67 participants and graded very low certainty. Same intervention, same outcome, two very different verdicts. Neither reading is wrong. They answer slightly different questions with different tolerances for what counts as evidence, and that difference is worth holding onto before either figure gets quoted back at you as settled.

The gap between those readings is the useful part. Camacho pooled before-and-after measurements from studies of varying design; Cochrane restricted itself to randomised trials and then graded how much the result could be trusted. When a stricter method produces a weaker answer, the weaker answer is usually the one to plan around.

For anyone reading this because of a partner's snoring rather than their own: snoring is a symptom that can have several explanations, and which one applies is a clinical question rather than a search-results question. SleepClinicFinder lists sleep study clinics and sleep apnea treatment providers across the region precisely so that question can be put to someone who can measure it.

Can myofunctional therapy replace CPAP?

Cochrane ran the head-to-head comparison, and the result is the single most important line for anyone hoping to swap one for the other. Against CPAP, myofunctional therapy "may result in little to no difference in daytime sleepiness (MD 0.30 points, 95% CI -1.65 to 2.25; one study, 54 participants; low-certainty evidence); and may increase AHI (MD 9.60 points, 95% CI 2.46 to 16.74; one study, 54 participants; low-certainty evidence)". One study, 54 people, low certainty — thin evidence, pointing the opposite way from the hope. Cochrane's own framing of why the question gets asked is fair: CPAP "is considered the first treatment option for most people with OSA", but "adherence to treatment is often suboptimal". The direction of that AHI estimate matters as much as its size, because it points away from substitution rather than toward it.

A 2026 network meta-analysis of 55 randomised controlled trials, published in Sleep Medicine, sorted the options against each other and landed in a similar place with more nuance. Its authors report that "CPAP was the most effective for reducing AHI and improving minimum SpO2", while "OMT outperformed CPAP in reducing daytime sleepiness". Their conclusion names the trade-off directly: "although CPAP remains the gold standard for treating OSA, combining CPAP with IMT and using OMT alone provide additional benefits for sleep quality and daytime sleepiness, respectively. MADs and OMT are viable alternatives for patients who are intolerant to CPAP."

Read those two together and the honest summary is that different measures rank the options differently, and that the choice is a clinical one made with the physician managing the diagnosis. Oral appliances sit in the same conversation — the 2026 review names mandibular advancement devices alongside myofunctional therapy — which is why SleepClinicFinder keeps dental sleep medicine, CPAP providers, and myofunctional therapy as separate, side-by-side verticals rather than ranking them.

Is myofunctional therapy used for children who snore or mouth-breathe?

Children are where the evidence is thinnest and the most recent reading is the most cautious. Camacho's 2015 review pooled just "two pediatric studies (25 patients)", and flagged that gap itself as a limitation: "although there were nine adult studies, a significant limitation for pediatric studies is that currently only two articles have been published." Cochrane found little more, reporting that in children, "compared to nasal washing alone, myofunctional therapy and nasal washing may result in little to no difference in AHI (MD 3.00, 95% CI -0.26 to 6.26; one study, 13 participants; low-certainty evidence)". Thirteen children, low certainty. That is the size of the foundation under a great deal of confident online advice. Small samples do not make a finding wrong. They do make it fragile, and fragile findings are the ones most likely to be revised by the next decent trial.

The 2026 pediatric meta-analysis in Sleep Medicine is blunter still. It included "eight articles investigating MFT (n = 7) and exercise (n = 1) ... most of which had serious risks of bias", found that among randomised trials "no statistically significant change was observed for MFT on AHI (4 studies, n = 174, MD: -1.68 (-3.61; 0.24), p = 0.07)", and concluded that "currently, no evidence supports isolated, active strategies as first-line treatment for pediatric OSDB". A guide that reported the 2015 pediatric numbers without that 2026 sentence attached would be misleading by omission.

There is also an age note from ASHA worth putting in front of parents: OMTs "may not be appropriate for children under the age of 4 years or who do not have the skills to self-monitor or follow directions". Snoring, mouth breathing, or restless nights in a child are observations to bring to a paediatrician. Hospital sleep programmes in this region are reached by physician referral — SickKids' respiratory medicine department states that referrals "must be made by a family physician or paediatrician" — so that conversation is the route in.

What does the research actually say — and what are its limits?

Cochrane's plain-language verdict is the sentence to carry away: compared to sham therapy, myofunctional therapy "probably reduces daytime sleepiness and may increase sleep quality in the short term. The certainty of the evidence for all comparisons ranges from moderate to very low, mainly due to lack of blinding of the assessors of subjective outcomes, incomplete outcome data and imprecision. More studies are needed." Broken out by outcome, the same review grades sleepiness as moderate certainty (ESS, MD -4.52 points, two studies, 82 participants), a large reduction in AHI as low certainty (MD -13.20 points, two studies, 82 participants), and snoring frequency as very low certainty. Those labels are the reviewers' own, and they do most of the work here. Certainty grades are not decoration: they are a statement of how far a number should move your thinking, and Cochrane placed most of this evidence well down that scale.

The pool being graded is small. Cochrane "found nine studies eligible for inclusion", analysing "a total of 347 participants, 69 of them women and 13 children", and recorded two silences that matter: "none of the studies assessed accidents, cardiovascular diseases or mortality outcomes", and "we sought data about adverse events, but none of the included studies reported these". Camacho's earlier meta-analysis was smaller again — 145 patients including 25 children — and listed its own weaknesses without flinching: most studies had low patient numbers, were run at single institutions, and "long-term follow-up for more than 6 mo is limited". Its heterogeneity statistics were high enough to note, with an I² of 91%.

One line from that 2015 paper is quotable enough to survive on its own: "MT provides a reduction in AHI of approximately 50% in adults and 62% in children". Detached from the caveats above it, it says less than it appears to. It is a pooled before-and-after change across 145 patients — not a count of how many people improved, not a prediction, and not a promise about any individual. Imaging research into what the exercises change anatomically is younger still: a 2026 systematic review of ultrasound assessment of the upper airway in adult OSA, published in the Journal of Clinical Medicine, reported that "a single study evaluated anatomical changes following myofunctional therapy, representing a nascent research area".

So the honest picture has four parts. The pooled adult signal is real but rests on small samples; Cochrane's randomised evidence ranges from moderate to very low certainty with no safety or cardiovascular data collected; CPAP still outperformed myofunctional therapy on AHI head to head; and the newest pediatric analysis found no statistically significant AHI change at all. What you do with that belongs in a conversation with the physician managing your care.

Frequently asked questions

Sources

Every figure quoted above comes from one of the reference pages below, each fetched and quoted in full in our research file for this guide. Discussion threads are listed separately and held to a narrower standard: we could not fetch those pages, so we quote a thread’s title only — checked against the public oEmbed record for that thread on the date shown — and never a comment inside it, and never a figure. Where we could not verify a claim, we cut it rather than publish it.

1. Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis — Camacho M, et al. Sleep 2015;38(5):669–675 (PMC). Fetched August 9, 2026.
2. Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea — Rueda JR, et al. Cochrane Database of Systematic Reviews 2020, CD013449 (PubMed 33141943). Fetched August 9, 2026.
3. Orofacial Myofunctional Disorders — Practice Portal — American Speech-Language-Hearing Association (ASHA). Fetched August 9, 2026.
4. Unregistered persons — public protection — College of Audiologists and Speech-Language Pathologists of Ontario (CASLPO). Fetched August 9, 2026.
5. Active strategies for children with obstructive sleep-disordered breathing: a systematic review and meta-analysis — Cnockaert P, Da Purificaçao J, Poncin W. Sleep Medicine 2026 Jun;142:108840 (PubMed 41762858). Fetched August 9, 2026.
6. Comparative effectiveness of CPAP and isolated or combined non-invasive therapies for obstructive sleep apnea: A network meta-analysis — Castellanos MFI, et al. Sleep Medicine 2026 May;141:108795 (PubMed 41679243). Fetched August 9, 2026.
7. Ultrasonographic Assessment of Upper Airway Structures in Adult Obstructive Sleep Apnea: A Systematic Review — Rodríguez Alcalá C, et al. Journal of Clinical Medicine 2026 Apr 23;15(9):3213 (PubMed 42122946). Fetched August 9, 2026.
8. Diagnosis and treatment of obstructive sleep apnea in adults — CMAJ 2017;189(48):E1481. Fetched August 9, 2026.
9. Respiratory Medicine — referrals and diagnostic services (incl. Sleep Lab) — The Hospital for Sick Children (SickKids). Fetched August 9, 2026.